Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Meiosis-Specific Nuclear Structural 1 (MNS1) (Middle Region) Peptide

MNS1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN980171

Quick Overview for Meiosis-Specific Nuclear Structural 1 (MNS1) (Middle Region) Peptide (ABIN980171)

Target

MNS1 (Meiosis-Specific Nuclear Structural 1 (MNS1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-MNS1 antibody (Catalog #: ARP57224_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    MNS1 (Meiosis-Specific Nuclear Structural 1 (MNS1))

    Background

    This gene encodes a protein highly similar to the mouse meiosis-specific nuclear structural 1 protein. The mouse protein was shown to be expressed at the pachytene stage during spermatogenesis and may function as a nuclear skeletal protein to regulate nuc

    Alias Symbols: FLJ11222, C6orf63, MNS1

    Protein Size: 495

    Molecular Weight

    60 kDa

    Gene ID

    57224

    NCBI Accession

    NM_018365, NP_060835

    UniProt

    Q8NEH6
You are here:
Chat with us!